News

Navacaprant, a monotherapy discovered at Scripps Research, showed clinically meaningful improvements for people with moderate-to-severe MDD in a recently completed Phase 2 study.

The program grant will support the development of high-affinity antibodies that can target skin and lung infections, as well as sexually transmitted diseases.

A leader in viral pathogenesis, Oldstone helped shape our modern understanding of viruses and how the immune system responds to these microbial threats.

Scripps Research study shows that analyzing T cells in blood samples could be used to select at-risk patients for type 1 diabetes preventive therapy.

The discovery by scientists from Scripps Research and Cardiff University paves the way for clinical trials that use patients’ own cells to treat Parkinson’s disease.

Eschenmoser pioneered key reactions in synthetic chemistry and shaped the understanding of how life may have first originated on Earth.

The award renews support for Scripps Research Translational Institute and partner organizations involved in expanding one of the largest and most inclusive health data resources of its kind.

The Translational Institute is harnessing genomic and digital technologies with machine learning to revolutionize health research.

The award will support Grotjahn’s study of how cells assemble the molecular machinery that governs programmed cell death.  

Scripps Research and University of Bologna scientists showed how excessive alcohol consumption in animals can hasten cognitive decline in those genetically predisposed to Alzheimer’s disease.

Scripps Research chemists add another powerful tool to their “molecular editing” toolkit for crafting pharmaceuticals and other valuable compounds.

By comparing the structures of protein complexes from different lineages of the dangerous Lassa virus, a Scripps Research team identified new antibodies and vaccine targets.

The new resource makes datasets more discoverable for life science community.

Commencement ceremony will be livestreamed via Zoom and on institute’s Facebook page.

Cline is recognized for her discoveries about the role of sensory experience in brain development.

Scripps Research chemists devise a new, C-H activation-based method for the synthesis of BCBs.

Liu’s research focuses on the biosynthesis of complex natural products in engineered microbes to harness, alter, or augment their innate bioactivities in the context of drug discovery.

Kelly’s groundbreaking work on protein misfolding has led to therapies for neurodegenerative and cardiovascular diseases.

By comparing how mirror image versions of small molecules impact clusters of proteins, Scripps Research scientists can identify potential new drug targets.

Study tested suvorexant (Belsomra®) for its ability to reduce drug-taking and block relapse.

A Scripps Research team showed how both alcohol intake and alcohol withdrawal can lead to increased pain and hypersensitivity.

Major grants from the National Institutes of Health and California Institute for Regenerative Medicine will support the development of state-of-the-art genomic tools.

Scripps Research vaccine candidate headed for clinical trials.

Scripps Research chemists developed a new biologic to work against the synthetic opioid carfentanil, which is 100 times more potent than fentanyl.